These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: [T-activin in the treatment of patients with recurrent erysipelas and concomitant eczema].
    Author: Frolov VM, Peresadin NA, Gaĭdash IS, Baskakov IN, Tishchenko NA.
    Journal: Vestn Dermatol Venerol; 1989; (9):47-51. PubMed ID: 2609765.
    Abstract:
    Increased levels of circulating immune complexes (CIC) have been revealed in 156 patients suffering from erysipelas and chronic eczema, 109 of these with frequent recurrences of erysipelatous inflammation, during all periods of the disease. The maximal rises of CIC levels have been associated with a combination of erysipelas relapse with eczema exacerbation, with the most pathogenic medium- and low-molecular complexes, making up together 80.4 +/- 4% of CICs, predominating in the blood. T-activin therapy results in an essential decrease of CIC level and in 2.5 times reduction of the number of early recurrences of erysipelas.
    [Abstract] [Full Text] [Related] [New Search]